In MCF-7 human breast cancer cells, zinc treatment of ZIP7-overexpressing cells significantly enhanced ZIP7-mediated zinc release, leading to the activation of downstream signaling pathways including PI3K/Akt, MAPK, and mTOR. This evidence concerns the gene SLC39A7 and breast cancer.